Abstract: Stabilized pharmaceutical formulations of insulin analogues and/ or insulin derivatives are disclosed. In particular the application is directed to a pharmaceutical formulation comprising (a) at least one analogue and/or derivative of insulin; and (b). Zn(ll); and (c). optionally protamine; wherein the pharmaceutical formulation is free of glycerol.
| # | Name | Date |
|---|---|---|
| 1 | Form 5 [06-06-2016(online)].pdf | 2016-06-06 |
| 2 | Form 3 [06-06-2016(online)].pdf | 2016-06-06 |
| 3 | Form 1 [06-06-2016(online)].pdf | 2016-06-06 |
| 4 | Description(Complete) [06-06-2016(online)].pdf | 2016-06-06 |
| 5 | Other Patent Document [02-09-2016(online)].pdf | 2016-09-02 |
| 6 | Other Patent Document [02-12-2016(online)].pdf | 2016-12-02 |
| 7 | Form 3 [05-12-2016(online)].pdf | 2016-12-05 |
| 8 | 201637019418-FORM 18 [05-01-2018(online)].pdf | 2018-01-05 |
| 9 | 201637019418-FER.pdf | 2020-06-21 |
| 10 | 201637019418-AbandonedLetter.pdf | 2024-07-18 |
| 1 | 2020-06-0314-13-32E_03-06-2020.pdf |